Ofokansi KC | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Ofokansi KC

Professor ,University of Nigeria, Nigeria  


 Professor Ofokansi obtained his B.Pharm., M. Pharm., and Ph.D degrees from the University of Nigeria, Nsukka. In  November 2000,  he took up a teaching  appointment in the Department of Pharmaceutics of his alma mater and rose to the rank of a Professor in October, 2011. Following a post-doctoral Research Fellowship Award in July 2006 by the Alexander von Humboldt Foundation, he moved over to Ludwig-Maximilians University, Munich, Germany in March 2007 where he worked on the development of a gelatin-based nanoparticulate formulation for the delivery of human insulin under the supervision of Prof. G. Winter and Dr. C. Coester before proceeding to the laboratory of Prof. Dr. GertFricker at Ruprechts-Karl University in Heidelberg, Germany where he continued with in vivo experiments using animal models to evaluate the efficacy of his formulations between May 2008 and April 30, 2009. Prof. Ofokansi has more than 70 scholarly publications in reputable local and international journals.Prof. Ofokansi has been  an approved supervisor for postgraduate studies in the University of Nigeria since 2006.

Research Interest



Global Speakers in the subject

Global Experts in the subject